Cempra, Inc. (CEMP)

[Johnny_C]

From the slide deck from MS

SOLITHROMYCIN (CABP)
• Pre-approval solithromycin patient request reduced to 6,000 to respond to CRL
• Trial to be conducted with 5-day, oral dosing only
• Oral-only safety study could support approval of oral solithromycin, with option to
seek future IV approval
• Oral-only protocol reduces cost, increases efficiency and utilizes dosing regimen
that appeared to have a lower ALT profile in Phase 3
• Seeking non-dilutive funding to support study


Looks like these Bozo's are also hiring 50 salespeople in US. UNREAL


http://files.shareholder.com/downloads/AMDA-RCGC8/5169787846x0x956369/CCB21B72-488B-4EAA-808C-31D3177B94B9/Cempra_FINAL_Sept_2017_Investor_Slides.pdf


These guys think so little of SOLI they wont fund the study with the cash they have.